Literature DB >> 1137502

Structural polypeptides of antigenically distinct strains of influenza B virus.

K Tobita, E D Kilbourne.   

Abstract

Analyses of the polypeptide composition of influenza B viruses by 13 per cent SDS-polyacrylamide gel electrophoresis are reported. The viruses contained polypeptides of eight species ranging in molecular weight from 27,000 to 78,000. Four of them were glocypeptides and were selectively removed from the surface of the virion by Bromelain treatment. One of the blycopeptides was identified as viral neuraminidase. Three antigenically distinct strains of influenza virus, B/Lee/40, B/Massachusetts/1/71 and B/Hong Kong/5/72, showed an essentially identical electrophoretic picture, although strain-to-strain difference was observed in the migration rate of HA1 and HA2 polypeptides.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1137502     DOI: 10.1007/bf01347978

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  10 in total

1.  Proteolytic cleavage of the hemagglutinin polypeptide of influenza virus. Function of the uncleaved polypeptide HA.

Authors:  S G Lazarowitz; R W Compans; P W Choppin
Journal:  Virology       Date:  1973-03       Impact factor: 3.616

2.  The size and shape of influenza virus neuraminidase.

Authors:  N G Wrigley; J J Skehel; P A Charlwood; C M Brand
Journal:  Virology       Date:  1973-02       Impact factor: 3.616

3.  Amino acid composition of polypeptides from influenza virus particles.

Authors:  W G Laver; N Baker
Journal:  J Gen Virol       Date:  1972-10       Impact factor: 3.891

4.  The polypeptides of influenza virus. VI. Composition of the neuraminidase.

Authors:  I Lazdins; E A Haslam; D O White
Journal:  Virology       Date:  1972-09       Impact factor: 3.616

5.  Antigenic relationship between influenza B viruses.

Authors:  P Chakraverty
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

6.  Reye's syndrome.

Authors:  H D Riley
Journal:  J Infect Dis       Date:  1972-01       Impact factor: 5.226

7.  Genetic recombination for antigenic markers of antigenically different strains of influenza B virus.

Authors:  K Tobita; E D Kilbourne
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

8.  Antigenic relationships between the neuraminidases of influenza B virus.

Authors:  P Chakraverty
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

9.  Polypeptide composition of Influenza B viruses and enzymes associated with the purified virus particles.

Authors:  J S Oxford
Journal:  J Virol       Date:  1973-10       Impact factor: 5.103

10.  Antigenic variants of influenza B virus.

Authors:  G C Schild; M S Pereira; P Chakraverty; M T Coleman; W R Dowdle; W K Chang
Journal:  Br Med J       Date:  1973-10-20
  10 in total
  5 in total

1.  Differences in the electrophoretic migration rates of polypeptides and RNAs of recent isolates of influenza B viruses.

Authors:  A L Hugentobler; G C Schild; J S Oxford
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

2.  Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes.

Authors:  M Krystal; R M Elliott; E W Benz; J F Young; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

3.  Structure of bromelain-released influenza virus haemagglutinin as revealed by electrophoresis, sedimentation and electron microscopy.

Authors:  M S Siniakov; I G Kharitonenkov; V B Grigorjev
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

4.  Preparation of projection-less particles from influenza virus and their messenger activities in prokaryotic and eukaryotic systems.

Authors:  E N Arida; T Hultin
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

5.  Influenza B virus genome: assignment of viral polypeptides to RNA segments.

Authors:  V R Racaniello; P Palese
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.